News
Search here results
search-total-matching109search-total-matching- Drug improves survival of patients with rare cancer by almost a quarter | UCL Cancer Institute - UCL – University College London
- Promising pre-clinical results for modified antibody targeting CD25 | UCL Cancer Institute - UCL – University College London
- International team receive $1.2 million boost for neuroendocrine cancer research | UCL Cancer Institute - UCL – University College London
- New region in noncoding DNA linked to leukaemia | UCL Cancer Institute - UCL – University College London
- Combining statins with chemotherapy does not extend survival in lung cancer | UCL Cancer Institute - UCL – University College London
- Scientists reveal variability as key mechanism behind adaptability of immune cells | UCL Cancer Institute - UCL – University College London
- HRH The Duke of Kent visits UCL Cancer Institute | UCL Cancer Institute - UCL – University College London
- New non-invasive test to detect bladder cancer developed | UCL Cancer Institute - UCL – University College London
- Landmark study provides insight into chemotherapy treatment for lung cancer patients | UCL Cancer Institute - UCL – University College London
- New funding for UCL cancer centres announced | UCL Cancer Institute - UCL – University College London
Please enable JavaScript to use this page or visit this page for a non javascript version.